Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-141-3p ABL1 1.13 0.09667 -0.28 0.25357 MirTarget -0.12 0 NA
2 hsa-miR-141-3p ABL2 1.13 0.09667 -0.13 0.63539 MirTarget; TargetScan; miRNATAP -0.16 0 NA
3 hsa-miR-141-3p ADAM22 1.13 0.09667 -0.88 0.25527 MirTarget -0.33 7.0E-5 NA
4 hsa-miR-141-3p ADARB1 1.13 0.09667 -0.6 0.08985 MirTarget -0.29 0 NA
5 hsa-miR-141-3p AKAP2 1.13 0.09667 -0.87 0.26357 TargetScan -0.48 0 NA
6 hsa-miR-141-3p AMOTL1 1.13 0.09667 -0.52 0.23224 TargetScan -0.26 0 NA
7 hsa-miR-141-3p AMZ1 1.13 0.09667 -0.84 0.19343 mirMAP -0.21 0.00226 NA
8 hsa-miR-141-3p ANGPTL1 1.13 0.09667 -0.94 0.28852 MirTarget -0.52 0 NA
9 hsa-miR-141-3p ANK2 1.13 0.09667 -0.87 0.25994 TargetScan; miRNATAP -0.48 0 NA
10 hsa-miR-141-3p ANKRD13A 1.13 0.09667 -0.83 0.00018 MirTarget -0.11 0 NA
11 hsa-miR-141-3p ANKRD44 1.13 0.09667 -1.3 0.04083 TargetScan -0.4 0 NA
12 hsa-miR-141-3p ANO6 1.13 0.09667 0.05 0.90255 MirTarget; TargetScan -0.13 0.00132 NA
13 hsa-miR-141-3p APBB2 1.13 0.09667 -0.11 0.68147 MirTarget; TargetScan -0.14 0 NA
14 hsa-miR-141-3p APOLD1 1.13 0.09667 0.05 0.92161 TargetScan -0.29 0 NA
15 hsa-miR-141-3p AR 1.13 0.09667 -0.52 0.55352 mirMAP -0.46 0 26062412; 22314666 miR 141 3p regulates the expression of androgen receptor by targeting its 3'UTR in prostate cancer LNCaP cells; After prostate cancer cell line LNCaP was transfected with miR-141-3p mimics expression levels of AR mRNA and protein in the LNCaP cells were detected by reverse transcription PCR and Western blotting respectively; The 3'untranslated regions 3'UTR of AR mRNA containing the binding site of miR-141-3p was amplified by PCR and inserted into pmiR-report vector a 3'downstream luciferase reporter gene; Transfection of miR-141-3p mimics decreased both mRNA and protein expression levels of AR in LNCaP cells; AR is a direct target gene of miR-141-3p;miR 141 modulates androgen receptor transcriptional activity in human prostate cancer cells through targeting the small heterodimer partner protein; Here we investigated the correlation of Shp expression with the cellular level of miR-141 and its effects on AR transcriptional activity in non-malignant and malignant human prostate epithelial cell lines; Phenethyl isothiocyanate a natural constituent of many edible cruciferous vegetables increased Shp expression downregulated miR-141 and inhibited AR transcriptional activity in LNCaP cells; Shp is a target for miR-141 and it is downregulated in cultured human PCa cells with the involvement of upregulation of miR-141 which promotes AR transcriptional activity
16 hsa-miR-141-3p ARHGAP23 1.13 0.09667 0.01 0.98674 TargetScan -0.19 0.00104 NA
17 hsa-miR-141-3p ARHGAP24 1.13 0.09667 -0.91 0.02885 TargetScan; miRNATAP -0.16 0.00023 NA
18 hsa-miR-141-3p ARID5B 1.13 0.09667 -0.68 0.07996 TargetScan; miRNATAP -0.31 0 NA
19 hsa-miR-141-3p ARL10 1.13 0.09667 -0.61 0.19487 mirMAP -0.23 0 NA
20 hsa-miR-141-3p ASTN1 1.13 0.09667 -1.5 0.17933 MirTarget; miRNATAP -0.25 0.04128 NA
21 hsa-miR-141-3p ATP6V1B2 1.13 0.09667 -0.68 0.00779 MirTarget; TargetScan; miRNATAP -0.11 0.00011 NA
22 hsa-miR-141-3p ATP8A2 1.13 0.09667 -0.04 0.95305 TargetScan -0.18 0.01465 NA
23 hsa-miR-141-3p ATXN1 1.13 0.09667 -0.51 0.09797 MirTarget; TargetScan; miRNATAP -0.18 0 NA
24 hsa-miR-141-3p BACH2 1.13 0.09667 -1.75 0.00364 TargetScan -0.43 0 NA
25 hsa-miR-141-3p BEND4 1.13 0.09667 -1.9 0.08641 TargetScan; miRNATAP -0.51 2.0E-5 NA
26 hsa-miR-141-3p BICD2 1.13 0.09667 -0.53 0.06121 MirTarget; miRNATAP -0.18 0 NA
27 hsa-miR-15a-5p BMI1 -0.74 0.01074 -0.18 0.45133 miRNAWalker2 validate; miRTarBase -0.14 0.0172 27596816 Our results suggest that overexpression of miR-15a and miR-16 mediates down-regulation of BMI1 and leads to mitochondrial mediated apoptosis
28 hsa-miR-362-3p BMI1 -1.21 0.01257 -0.18 0.45133 miRanda -0.11 0.00173 NA
29 hsa-miR-455-5p BMI1 -0.23 0.54044 -0.18 0.45133 miRanda -0.11 0.01889 NA
30 hsa-miR-590-3p BMI1 -0.92 0.03456 -0.18 0.45133 miRanda; mirMAP -0.12 0.00201 NA
31 hsa-miR-141-3p BNC2 1.13 0.09667 -0.15 0.8368 TargetScan -0.57 0 NA
32 hsa-miR-141-3p BTN2A2 1.13 0.09667 -1.12 0.00207 mirMAP -0.22 0 NA
33 hsa-miR-141-3p BVES 1.13 0.09667 -0.04 0.94915 mirMAP -0.28 1.0E-5 NA
34 hsa-miR-141-3p C11orf21 1.13 0.09667 -1.67 0.02483 mirMAP -0.39 0 NA
35 hsa-miR-141-3p C20orf194 1.13 0.09667 -0.45 0.19186 TargetScan; mirMAP -0.11 0.00365 NA
36 hsa-miR-141-3p C21orf91 1.13 0.09667 -0.85 0.01519 TargetScan -0.23 0 NA
37 hsa-miR-141-3p C6orf120 1.13 0.09667 -0.4 0.05976 TargetScan -0.11 0 NA
38 hsa-miR-141-3p CACNA1E 1.13 0.09667 -0.51 0.44626 MirTarget; TargetScan; miRNATAP -0.45 0 NA
39 hsa-miR-141-3p CACNA1I 1.13 0.09667 -0.24 0.78112 TargetScan -0.31 0.00117 NA
40 hsa-miR-141-3p CACNA2D1 1.13 0.09667 -0.16 0.86886 TargetScan -0.49 0 NA
41 hsa-miR-141-3p CADM1 1.13 0.09667 -0.53 0.36556 MirTarget; TargetScan -0.15 0.01458 NA
42 hsa-miR-141-3p CALU 1.13 0.09667 0.41 0.28312 TargetScan -0.18 0 NA
43 hsa-miR-141-3p CAMK4 1.13 0.09667 -0.61 0.35184 mirMAP -0.28 5.0E-5 NA
44 hsa-miR-141-3p CBL 1.13 0.09667 -0.48 0.10129 MirTarget; TargetScan; mirMAP -0.17 0 NA
45 hsa-miR-141-3p CCDC80 1.13 0.09667 0.02 0.97481 MirTarget; TargetScan -0.57 0 NA
46 hsa-miR-141-3p CD274 1.13 0.09667 -0.72 0.22253 MirTarget -0.23 0.0003 NA
47 hsa-miR-141-3p CDC14A 1.13 0.09667 -0.8 0.05646 TargetScan; miRNATAP -0.23 0 NA
48 hsa-miR-141-3p CDC42EP3 1.13 0.09667 0.05 0.88181 MirTarget; TargetScan -0.12 0.00065 NA
49 hsa-miR-141-3p CDON 1.13 0.09667 -0.13 0.81496 TargetScan; miRNATAP -0.18 0.00203 NA
50 hsa-miR-141-3p CDV3 1.13 0.09667 -0.37 0.06194 TargetScan; miRNATAP -0.1 0 NA
51 hsa-miR-141-3p CELF2 1.13 0.09667 -1.75 0.00444 mirMAP; miRNATAP -0.53 0 NA
52 hsa-miR-141-3p CEP170 1.13 0.09667 -0.54 0.15049 TargetScan -0.2 0 NA
53 hsa-miR-141-3p CFL2 1.13 0.09667 -0.4 0.27702 TargetScan -0.21 0 NA
54 hsa-miR-141-3p CHRDL1 1.13 0.09667 -0.73 0.53577 MirTarget; TargetScan -0.9 0 NA
55 hsa-miR-141-3p CLIC4 1.13 0.09667 -0.37 0.38824 MirTarget -0.3 0 NA
56 hsa-miR-141-3p CLSPN 1.13 0.09667 0.41 0.57124 MirTarget -0.25 0.00127 NA
57 hsa-miR-141-3p CNTN1 1.13 0.09667 -0.06 0.94437 MirTarget; TargetScan; miRNATAP -0.29 0.00358 NA
58 hsa-miR-141-3p COL11A1 1.13 0.09667 1.03 0.52179 miRNATAP -0.61 0.00037 NA
59 hsa-miR-141-3p COL15A1 1.13 0.09667 0.39 0.50342 MirTarget -0.32 0 NA
60 hsa-miR-141-3p COL8A1 1.13 0.09667 0.61 0.5252 mirMAP -0.5 0 NA
61 hsa-miR-141-3p CORO1C 1.13 0.09667 -0.17 0.56501 TargetScan -0.17 0 NA
62 hsa-miR-141-3p CREB3L2 1.13 0.09667 0.1 0.72448 MirTarget -0.13 6.0E-5 NA
63 hsa-miR-141-3p CREB5 1.13 0.09667 -1.59 0.00384 mirMAP -0.22 0.0002 NA
64 hsa-miR-141-3p CRLF3 1.13 0.09667 -0.46 0.08918 TargetScan -0.15 0 NA
65 hsa-miR-141-3p CRYBG3 1.13 0.09667 -0.21 0.58758 MirTarget -0.16 8.0E-5 NA
66 hsa-miR-141-3p CSF3 1.13 0.09667 -0.85 0.51687 TargetScan; miRNATAP -0.48 0.00061 NA
67 hsa-miR-141-3p CSTA 1.13 0.09667 -0.68 0.38523 MirTarget -0.21 0.01287 NA
68 hsa-miR-141-3p CTSB 1.13 0.09667 -0.34 0.3287 mirMAP -0.17 1.0E-5 NA
69 hsa-miR-141-3p CXCL12 1.13 0.09667 -1.19 0.1171 miRNATAP -0.59 0 NA
70 hsa-miR-141-3p CYLD 1.13 0.09667 -0.58 0.0188 mirMAP -0.12 0 NA
71 hsa-miR-141-3p CYP26B1 1.13 0.09667 -0.14 0.81629 MirTarget; TargetScan; miRNATAP -0.33 0 NA
72 hsa-miR-141-3p DCP2 1.13 0.09667 -0.45 0.02171 MirTarget; TargetScan -0.12 0 NA
73 hsa-miR-141-3p DCUN1D3 1.13 0.09667 -0.02 0.94021 MirTarget; TargetScan -0.13 0 NA
74 hsa-miR-141-3p DDI2 1.13 0.09667 -0.23 0.72424 mirMAP -0.17 0.01803 NA
75 hsa-miR-141-3p DIO2 1.13 0.09667 1.45 0.03366 miRNATAP -0.31 3.0E-5 NA
76 hsa-miR-141-3p DLC1 1.13 0.09667 -0.71 0.10958 TargetScan; miRNATAP -0.32 0 26278151 MicroRNA 141 regulates the tumour suppressor DLC1 in colorectal cancer; Luciferase reporter assays and Western blots showed that DLC1 was a direct target of miR-141 in CRC; The expression levels of miR-141 were obviously up-regulated in CRC tissues compared to non-cancerous tissues while DLC1 expression levels were down-regulated in a high proportion of clinical samples 14/18; In addition correlation analyses revealed negative correlation between miR-141 levels and DLC1 expression levels in CRC tissues; In conclusion we demonstrated that miR-141 is up-regulated in CRC and acts as a functional oncogene by targeting DLC1
77 hsa-miR-141-3p DLX5 1.13 0.09667 -0.22 0.77457 miRNAWalker2 validate; miRTarBase -0.2 0.0163 NA
78 hsa-miR-141-3p DOCK4 1.13 0.09667 -0.58 0.16909 MirTarget; TargetScan -0.18 5.0E-5 NA
79 hsa-miR-141-3p DPYSL3 1.13 0.09667 -0.46 0.37566 TargetScan -0.31 0 NA
80 hsa-miR-141-3p DR1 1.13 0.09667 0.07 0.74852 MirTarget; TargetScan -0.1 1.0E-5 NA
81 hsa-miR-141-3p DSEL 1.13 0.09667 -0.27 0.62922 TargetScan -0.23 0.00015 NA
82 hsa-miR-141-3p DUSP1 1.13 0.09667 -0.09 0.86695 TargetScan -0.33 0 NA
83 hsa-miR-141-3p DYNC1I1 1.13 0.09667 0.74 0.31036 MirTarget -0.18 0.02299 NA
84 hsa-miR-141-3p DZIP1 1.13 0.09667 -0.6 0.27307 TargetScan; miRNATAP -0.21 0.00025 NA
85 hsa-miR-141-3p E2F3 1.13 0.09667 -0.2 0.50008 miRNAWalker2 validate; TargetScan; miRNATAP -0.12 0.00019 26233544 MiR 141 Inhibits Gastric Cancer Proliferation by Interacting with Long Noncoding RNA MEG3 and Down Regulating E2F3 Expression; QRT-PCR was used to detect miR-141 MEG3 and E2F3 in gastric tissues and cells; Western blot and luciferase activity were used to identify E2F3 as one of the direct targets of miR-141; E2F3 was identified as a target of miR-141 and its inhibition significantly reduced MEG3 expression; E2F3 expression was also found to be negatively associated with both MEG3 and miR-141; E2F3 over-expression partly reversed the changes caused by transfection of miR-141 mimic and inhibition of miR-141 or MEG3 overrides MEG3- or miR-141-induced modulation of cell growth in GC; These findings together suggested that miR-141 could be interacting with MEG3 and targeting E2F3 and these factors may play important anti-tumor effects in GC pathogenesis and provide therapeutic targets in the clinics
86 hsa-miR-141-3p EGR2 1.13 0.09667 -0.6 0.36333 TargetScan; miRNATAP -0.39 0 NA
87 hsa-miR-141-3p EHD3 1.13 0.09667 -0.58 0.13605 mirMAP -0.27 0 NA
88 hsa-miR-141-3p ELK3 1.13 0.09667 -0.28 0.5575 TargetScan -0.26 0 NA
89 hsa-miR-141-3p EPB41L3 1.13 0.09667 -0.67 0.22434 miRNATAP -0.29 0 NA
90 hsa-miR-141-3p ERG 1.13 0.09667 -1 0.04239 MirTarget; TargetScan -0.37 0 NA
91 hsa-miR-141-3p ETS1 1.13 0.09667 -0.99 0.01795 mirMAP -0.31 0 NA
92 hsa-miR-141-3p FAM133A 1.13 0.09667 0.37 0.63896 mirMAP -0.25 0.00298 NA
93 hsa-miR-141-3p FAM168A 1.13 0.09667 -0.35 0.46871 TargetScan -0.22 2.0E-5 NA
94 hsa-miR-141-3p FAM20C 1.13 0.09667 0.18 0.60037 MirTarget -0.13 0.00033 NA
95 hsa-miR-141-3p FAM26E 1.13 0.09667 -0.42 0.45631 mirMAP -0.43 0 NA
96 hsa-miR-141-3p FAT3 1.13 0.09667 -1.22 0.10046 MirTarget; miRNATAP -0.45 0 NA
97 hsa-miR-141-3p FER 1.13 0.09667 -0.09 0.82691 mirMAP -0.13 0.0023 NA
98 hsa-miR-141-3p FGF13 1.13 0.09667 -0.98 0.1122 TargetScan -0.15 0.02579 NA
99 hsa-miR-141-3p FKBP5 1.13 0.09667 -0.64 0.31693 TargetScan -0.32 0 NA
100 hsa-miR-141-3p FLI1 1.13 0.09667 -1.49 0.00419 TargetScan -0.45 0 NA
101 hsa-miR-141-3p FOXN3 1.13 0.09667 -0.48 0.10355 MirTarget; TargetScan; miRNATAP -0.2 0 NA
102 hsa-miR-141-3p FOXO1 1.13 0.09667 -0.73 0.05833 mirMAP -0.26 0 NA
103 hsa-miR-141-3p FOXP2 1.13 0.09667 0.26 0.75107 TargetScan -0.34 0.0001 NA
104 hsa-miR-141-3p FRMD4A 1.13 0.09667 -1.3 0.00053 MirTarget; TargetScan; miRNATAP -0.24 0 NA
105 hsa-miR-141-3p FRMD6 1.13 0.09667 -0.32 0.5949 MirTarget; TargetScan; miRNATAP -0.33 0 NA
106 hsa-miR-141-3p FZD4 1.13 0.09667 -0.61 0.11853 TargetScan -0.28 0 NA
107 hsa-miR-141-3p GAB2 1.13 0.09667 -0.37 0.19352 mirMAP -0.12 3.0E-5 NA
108 hsa-miR-141-3p GATA3 1.13 0.09667 0.31 0.69983 TargetScan -0.25 0.00281 NA
109 hsa-miR-141-3p GDF6 1.13 0.09667 0.41 0.59382 TargetScan -0.46 0 NA
110 hsa-miR-141-3p GEM 1.13 0.09667 0.03 0.9651 MirTarget -0.4 0 NA
111 hsa-miR-141-3p GFRA1 1.13 0.09667 -0.09 0.91461 mirMAP -0.36 8.0E-5 NA
112 hsa-miR-141-3p GFRA2 1.13 0.09667 -1.27 0.07593 mirMAP -0.45 0 NA
113 hsa-miR-141-3p GIT2 1.13 0.09667 -0.68 0.00253 MirTarget -0.14 0 NA
114 hsa-miR-141-3p GJC1 1.13 0.09667 0.22 0.60528 MirTarget; TargetScan; miRNATAP -0.27 0 NA
115 hsa-miR-141-3p GLCCI1 1.13 0.09667 -0.47 0.23746 MirTarget; TargetScan; miRNATAP -0.15 0.00028 NA
116 hsa-miR-141-3p GLDN 1.13 0.09667 -1.2 0.08392 MirTarget -0.19 0.01159 NA
117 hsa-miR-141-3p GLI2 1.13 0.09667 0.04 0.95178 MirTarget -0.36 0 NA
118 hsa-miR-141-3p GLRX 1.13 0.09667 -0.37 0.29901 MirTarget; TargetScan; miRNATAP -0.13 0.00035 NA
119 hsa-miR-141-3p GNA12 1.13 0.09667 -0.27 0.27167 mirMAP -0.13 0 NA
120 hsa-miR-141-3p GNA13 1.13 0.09667 -0.51 0.05072 MirTarget; TargetScan -0.14 0 NA
121 hsa-miR-141-3p GNG7 1.13 0.09667 -1.53 0.0195 MirTarget; TargetScan; miRNATAP -0.15 0.03175 NA
122 hsa-miR-141-3p GPAM 1.13 0.09667 -0.86 0.0486 MirTarget -0.19 7.0E-5 NA
123 hsa-miR-141-3p GPC6 1.13 0.09667 0.23 0.70012 TargetScan -0.3 0 NA
124 hsa-miR-141-3p GPM6B 1.13 0.09667 -0.6 0.33946 TargetScan; miRNATAP -0.38 0 NA
125 hsa-miR-141-3p GPR137B 1.13 0.09667 -0.13 0.6871 TargetScan -0.17 0 NA
126 hsa-miR-141-3p GPR137C 1.13 0.09667 -0.74 0.0544 TargetScan; miRNATAP -0.14 0.00063 NA
127 hsa-miR-141-3p GPR174 1.13 0.09667 -1.4 0.13498 TargetScan -0.66 0 NA
128 hsa-miR-141-3p GRAP2 1.13 0.09667 -1.06 0.10477 mirMAP -0.38 0 NA
129 hsa-miR-141-3p GRIK3 1.13 0.09667 -0.66 0.41704 mirMAP -0.26 0.00292 NA
130 hsa-miR-141-3p GRIN3A 1.13 0.09667 -0.82 0.03097 TargetScan; miRNATAP -0.15 0.00025 NA
131 hsa-miR-141-3p HAS2 1.13 0.09667 0.52 0.52522 MirTarget -0.41 0 NA
132 hsa-miR-141-3p HECW1 1.13 0.09667 0.52 0.58204 TargetScan -0.4 7.0E-5 NA
133 hsa-miR-141-3p HEYL 1.13 0.09667 0.19 0.73062 mirMAP -0.22 0.00021 NA
134 hsa-miR-141-3p HGF 1.13 0.09667 -0.89 0.25864 MirTarget; TargetScan -0.57 0 NA
135 hsa-miR-141-3p HIPK3 1.13 0.09667 -0.25 0.7029 MirTarget; TargetScan -0.19 0.00673 NA
136 hsa-miR-141-3p HLF 1.13 0.09667 -0.66 0.37924 TargetScan -0.17 0.03646 NA
137 hsa-miR-141-3p HS3ST3B1 1.13 0.09667 -0.6 0.33145 mirMAP -0.17 0.00957 NA
138 hsa-miR-141-3p HSPA13 1.13 0.09667 0.02 0.95259 TargetScan -0.1 0.00769 NA
139 hsa-miR-141-3p HTR2A 1.13 0.09667 1.09 0.2119 TargetScan -0.56 0 NA
140 hsa-miR-141-3p ICOSLG 1.13 0.09667 -0.7 0.05851 mirMAP -0.18 0 NA
141 hsa-miR-141-3p IGDCC4 1.13 0.09667 -0.95 0.14689 TargetScan; miRNATAP -0.54 0 NA
142 hsa-miR-141-3p IGF2 1.13 0.09667 0.45 0.58211 MirTarget; TargetScan -0.38 1.0E-5 NA
143 hsa-miR-141-3p IGSF6 1.13 0.09667 -1.79 0.00917 TargetScan -0.46 0 NA
144 hsa-miR-141-3p IL18R1 1.13 0.09667 -0.25 0.60736 MirTarget -0.25 0 NA
145 hsa-miR-141-3p IL6R 1.13 0.09667 -0.25 0.69611 MirTarget -0.17 0.01362 NA
146 hsa-miR-141-3p IRAK3 1.13 0.09667 -0.55 0.29063 mirMAP -0.21 0.00013 NA
147 hsa-miR-141-3p ITGAV 1.13 0.09667 -0.33 0.42648 MirTarget -0.13 0.00399 NA
148 hsa-miR-141-3p ITSN1 1.13 0.09667 -0.16 0.58414 TargetScan; mirMAP -0.18 0 NA
149 hsa-miR-141-3p JAZF1 1.13 0.09667 -0.56 0.09201 MirTarget; miRNATAP -0.14 0.00013 NA
150 hsa-miR-141-3p KATNAL1 1.13 0.09667 -0.34 0.35357 TargetScan -0.14 0.00058 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 72 1395 1.616e-15 7.519e-12
2 REGULATION OF CELL DIFFERENTIATION 71 1492 1.52e-13 3.536e-10
3 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 60 1142 2.565e-13 3.978e-10
4 POSITIVE REGULATION OF CELL DIFFERENTIATION 49 823 5.863e-13 6.82e-10
5 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 53 957 1.024e-12 9.499e-10
6 CELLULAR COMPONENT MORPHOGENESIS 51 900 1.225e-12 9.499e-10
7 CARDIOVASCULAR SYSTEM DEVELOPMENT 47 788 1.718e-12 9.994e-10
8 CIRCULATORY SYSTEM DEVELOPMENT 47 788 1.718e-12 9.994e-10
9 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 37 513 2.02e-12 1.044e-09
10 CELL DEVELOPMENT 66 1426 4.504e-12 2.096e-09
11 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 60 1275 2.568e-11 1.086e-08
12 TISSUE DEVELOPMENT 66 1518 6.875e-11 2.666e-08
13 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 70 1672 8.759e-11 3.135e-08
14 NEUROGENESIS 62 1402 1.463e-10 4.862e-08
15 VASCULATURE DEVELOPMENT 32 469 2.789e-10 8.651e-08
16 POSITIVE REGULATION OF NEURON DIFFERENTIATION 25 306 6.911e-10 1.913e-07
17 REGULATION OF CELL ADHESION 37 629 6.991e-10 1.913e-07
18 REGULATION OF NEURON DIFFERENTIATION 34 554 1.213e-09 2.687e-07
19 BLOOD VESSEL MORPHOGENESIS 27 364 1.202e-09 2.687e-07
20 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 49 1021 1.136e-09 2.687e-07
21 REGULATION OF CELL MORPHOGENESIS 34 552 1.105e-09 2.687e-07
22 LOCOMOTION 51 1114 2.494e-09 5.276e-07
23 REGULATION OF CELL PROJECTION ORGANIZATION 33 558 5.389e-09 1.09e-06
24 NEURON PROJECTION MORPHOGENESIS 27 402 1.015e-08 1.968e-06
25 CELL PROJECTION ORGANIZATION 43 902 1.592e-08 2.893e-06
26 REGULATION OF CELLULAR COMPONENT MOVEMENT 39 771 1.616e-08 2.893e-06
27 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 30 498 1.822e-08 3.139e-06
28 POSITIVE REGULATION OF CELL DEVELOPMENT 29 472 2.065e-08 3.432e-06
29 POSITIVE REGULATION OF CELL PROLIFERATION 40 814 2.315e-08 3.714e-06
30 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 38 750 2.396e-08 3.716e-06
31 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 36 689 2.647e-08 3.973e-06
32 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 25 368 2.899e-08 4.215e-06
33 EMBRYONIC MORPHOGENESIS 31 539 3.032e-08 4.276e-06
34 CELL PART MORPHOGENESIS 34 633 3.393e-08 4.643e-06
35 NEURON DIFFERENTIATION 41 874 5.497e-08 7.307e-06
36 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 27 437 5.752e-08 7.435e-06
37 POSITIVE REGULATION OF GENE EXPRESSION 64 1733 8.275e-08 1.041e-05
38 SKELETAL SYSTEM DEVELOPMENT 27 455 1.304e-07 1.588e-05
39 NEURON PROJECTION DEVELOPMENT 30 545 1.331e-07 1.588e-05
40 ANGIOGENESIS 21 293 1.556e-07 1.81e-05
41 REGULATION OF CELL CELL ADHESION 24 380 2.139e-07 2.369e-05
42 REGULATION OF NEURON PROJECTION DEVELOPMENT 25 408 2.111e-07 2.369e-05
43 GROWTH 25 410 2.315e-07 2.505e-05
44 NEURON DEVELOPMENT 34 687 2.369e-07 2.505e-05
45 REGULATION OF EXTENT OF CELL GROWTH 12 101 3.871e-07 3.915e-05
46 REGULATION OF CELL DEVELOPMENT 38 836 3.844e-07 3.915e-05
47 REGULATION OF CELL ACTIVATION 27 484 4.438e-07 4.302e-05
48 POSITIVE REGULATION OF OSSIFICATION 11 84 4.387e-07 4.302e-05
49 REGULATION OF AXONOGENESIS 15 168 6.087e-07 5.78e-05
50 HEART DEVELOPMENT 26 466 7.267e-07 6.763e-05
51 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 63 1805 7.715e-07 7.039e-05
52 REGULATION OF CELL SIZE 15 172 8.227e-07 7.361e-05
53 CELL MOTILITY 37 835 1.016e-06 8.751e-05
54 LOCALIZATION OF CELL 37 835 1.016e-06 8.751e-05
55 MUSCLE TISSUE DEVELOPMENT 19 275 1.062e-06 8.983e-05
56 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 20 303 1.129e-06 9.379e-05
57 ORGAN MORPHOGENESIS 37 841 1.203e-06 9.821e-05
58 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 21 337 1.538e-06 0.0001234
59 EMBRYO DEVELOPMENT 38 894 1.954e-06 0.0001541
60 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 41 1004 2.055e-06 0.0001593
61 MUSCLE STRUCTURE DEVELOPMENT 24 432 2.108e-06 0.0001608
62 REGULATION OF DEVELOPMENTAL GROWTH 19 289 2.222e-06 0.0001667
63 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 37 867 2.451e-06 0.000181
64 MESENCHYME DEVELOPMENT 15 190 2.876e-06 0.0002091
65 BIOLOGICAL ADHESION 41 1032 4.047e-06 0.0002897
66 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 60 1784 4.829e-06 0.0003404
67 NEGATIVE REGULATION OF CELL COMMUNICATION 45 1192 5.037e-06 0.0003498
68 REGULATION OF HOMOTYPIC CELL CELL ADHESION 19 307 5.358e-06 0.0003666
69 REGULATION OF CELLULAR COMPONENT SIZE 20 337 5.693e-06 0.0003839
70 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 32 724 5.961e-06 0.0003963
71 TAXIS 24 464 7.13e-06 0.0004673
72 NEURON PROJECTION GUIDANCE 15 205 7.294e-06 0.0004714
73 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 16 232 7.72e-06 0.000492
74 MESENCHYMAL CELL DIFFERENTIATION 12 134 7.899e-06 0.0004967
75 INTRACELLULAR SIGNAL TRANSDUCTION 54 1572 8.509e-06 0.000521
76 POSITIVE REGULATION OF CELL ADHESION 21 376 8.48e-06 0.000521
77 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 56 1656 8.972e-06 0.0005422
78 TUBE MORPHOGENESIS 19 323 1.105e-05 0.0006591
79 NEGATIVE REGULATION OF CELL DIFFERENTIATION 28 609 1.133e-05 0.0006673
80 POSITIVE REGULATION OF RESPONSE TO STIMULUS 62 1929 1.363e-05 0.0007735
81 POSITIVE REGULATION OF CELL CELL ADHESION 16 243 1.38e-05 0.0007735
82 UROGENITAL SYSTEM DEVELOPMENT 18 299 1.378e-05 0.0007735
83 STEM CELL DIFFERENTIATION 14 190 1.357e-05 0.0007735
84 POSITIVE REGULATION OF LOCOMOTION 22 420 1.416e-05 0.000778
85 REGULATION OF EPITHELIAL CELL MIGRATION 13 166 1.438e-05 0.000778
86 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 48 1360 1.428e-05 0.000778
87 DEVELOPMENTAL GROWTH 19 333 1.694e-05 0.0009058
88 SENSORY ORGAN DEVELOPMENT 24 493 1.938e-05 0.001013
89 REGULATION OF CELL PROLIFERATION 51 1496 1.917e-05 0.001013
90 OSSIFICATION 16 251 2.059e-05 0.001065
91 RESPONSE TO WOUNDING 26 563 2.171e-05 0.00111
92 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 10 103 2.232e-05 0.001129
93 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 10 104 2.429e-05 0.001215
94 DIGESTIVE TRACT MORPHOGENESIS 7 48 2.78e-05 0.001376
95 REGULATION OF FAT CELL DIFFERENTIATION 10 106 2.869e-05 0.001376
96 CARDIAC SEPTUM DEVELOPMENT 9 85 2.868e-05 0.001376
97 REGULATION OF ANATOMICAL STRUCTURE SIZE 23 472 2.846e-05 0.001376
98 REGULATION OF OSSIFICATION 13 178 3.016e-05 0.001432
99 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 8 67 3.328e-05 0.001564
100 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 6 34 3.443e-05 0.001589
101 SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT 5 21 3.45e-05 0.001589
102 ESTABLISHMENT OF CELL POLARITY 9 88 3.79e-05 0.001726
103 REGULATION OF PHOSPHORUS METABOLIC PROCESS 53 1618 3.822e-05 0.001726
104 NEURON MIGRATION 10 110 3.955e-05 0.00177
105 CENTRAL NERVOUS SYSTEM DEVELOPMENT 34 872 4.102e-05 0.001818
106 EYE DEVELOPMENT 18 326 4.33e-05 0.001901
107 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 32 801 4.391e-05 0.001902
108 REGULATION OF PROTEIN MODIFICATION PROCESS 55 1710 4.416e-05 0.001902
109 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 58 1848 5.303e-05 0.002243
110 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 12 162 5.292e-05 0.002243
111 INNER EAR MORPHOGENESIS 9 92 5.399e-05 0.002263
112 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 11 141 6.764e-05 0.00281
113 EMBRYONIC ORGAN MORPHOGENESIS 16 279 7.347e-05 0.003009
114 SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE 4 13 7.373e-05 0.003009
115 REGULATION OF WNT SIGNALING PATHWAY 17 310 7.651e-05 0.003096
116 MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 6 39 7.723e-05 0.003098
117 POSITIVE REGULATION OF MOLECULAR FUNCTION 56 1791 8.038e-05 0.003197
118 MEMBRANE ASSEMBLY 5 25 8.473e-05 0.003341
119 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 36 983 8.75e-05 0.003421
120 REGULATION OF ACTIVATED T CELL PROLIFERATION 6 40 8.945e-05 0.003469
121 VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 4 14 0.0001017 0.003911
122 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 6 41 0.0001032 0.003934
123 VASCULOGENESIS 7 59 0.0001081 0.004089
124 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 40 1152 0.0001109 0.004162
125 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 37 1036 0.0001159 0.004247
126 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 37 1036 0.0001159 0.004247
127 TUBE DEVELOPMENT 24 552 0.0001144 0.004247
128 AUTONOMIC NERVOUS SYSTEM DEVELOPMENT 6 42 0.0001185 0.004307
129 REGULATION OF LEUKOCYTE DIFFERENTIATION 14 232 0.0001206 0.004351
130 MEMBRANE DEPOLARIZATION 7 61 0.0001339 0.004793
131 REGULATION OF KINASE ACTIVITY 30 776 0.0001363 0.004843
132 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 11 154 0.0001491 0.005256
133 SINGLE ORGANISM CELL ADHESION 21 459 0.0001527 0.005341
134 HEAD DEVELOPMENT 28 709 0.0001607 0.005579
135 REGULATION OF CARTILAGE DEVELOPMENT 7 63 0.0001645 0.005635
136 SENSORY ORGAN MORPHOGENESIS 14 239 0.0001647 0.005635
137 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 39 1135 0.0001681 0.005711
138 REGULATION OF T CELL DIFFERENTIATION 9 107 0.0001746 0.005887
139 STEM CELL DIVISION 5 29 0.0001782 0.005903
140 HEART MORPHOGENESIS 13 212 0.0001789 0.005903
141 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 4 16 0.0001795 0.005903
142 REGULATION OF TRANSPORT 55 1804 0.0001801 0.005903
143 REGULATION OF ORGAN MORPHOGENESIS 14 242 0.0001875 0.0061
144 IMMUNE SYSTEM PROCESS 59 1984 0.0001986 0.006378
145 REGULATION OF CHONDROCYTE DIFFERENTIATION 6 46 0.0001987 0.006378
146 MEMBRANE BIOGENESIS 5 30 0.0002106 0.006711
147 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 20 437 0.0002174 0.00688
148 REGULATION OF BODY FLUID LEVELS 22 506 0.0002195 0.006886
149 CELL GROWTH 10 135 0.0002205 0.006886
150 MUSCLE ORGAN DEVELOPMENT 15 277 0.0002294 0.007117
151 EMBRYONIC ORGAN DEVELOPMENT 19 406 0.0002352 0.007248
152 HINDBRAIN DEVELOPMENT 10 137 0.0002485 0.00746
153 SKELETAL MUSCLE ORGAN DEVELOPMENT 10 137 0.0002485 0.00746
154 REGULATION OF IMMUNE SYSTEM PROCESS 45 1403 0.0002481 0.00746
155 EAR MORPHOGENESIS 9 112 0.0002467 0.00746
156 IMMUNE SYSTEM DEVELOPMENT 24 582 0.0002519 0.00748
157 REGULATION OF INTERLEUKIN 2 PRODUCTION 6 48 0.0002524 0.00748
158 POSITIVE REGULATION OF CELL ACTIVATION 16 311 0.0002557 0.007529
159 REGULATION OF ACTIN FILAMENT BASED PROCESS 16 312 0.000265 0.007707
160 PROTEIN AUTOPHOSPHORYLATION 12 192 0.0002644 0.007707
161 REGULATION OF CELL SHAPE 10 139 0.0002794 0.008075
162 REGULATION OF HEMOPOIESIS 16 314 0.0002846 0.008169
163 CONNECTIVE TISSUE DEVELOPMENT 12 194 0.0002908 0.008169
164 REGULATION OF ACTIN CYTOSKELETON REORGANIZATION 5 32 0.0002886 0.008169
165 NEGATIVE REGULATION OF CELL ADHESION 13 223 0.0002932 0.008169
166 BEHAVIOR 22 516 0.0002878 0.008169
167 POSITIVE REGULATION OF AXONOGENESIS 7 69 0.0002916 0.008169
168 CARDIAC MUSCLE TISSUE DEVELOPMENT 10 140 0.000296 0.008198
169 REGULATION OF EPITHELIAL CELL PROLIFERATION 15 285 0.0003111 0.008565
170 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 7 70 0.0003189 0.008729
171 REGULATION OF ION TRANSPORT 24 592 0.0003228 0.008783
172 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 12 197 0.0003345 0.00901
173 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 5 33 0.000335 0.00901
174 ACTIN FILAMENT BASED MOVEMENT 8 93 0.0003419 0.009144
175 REGULATION OF GROWTH 25 633 0.0003591 0.009548
176 TELENCEPHALON DEVELOPMENT 13 228 0.0003629 0.009594
177 REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 4 19 0.0003659 0.009618
178 CARDIAC CHAMBER DEVELOPMENT 10 144 0.000371 0.009697
NumGOOverlapSizeP ValueAdj. P Value
1 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 36 629 2.5e-09 1.822e-06
2 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 53 1199 3.922e-09 1.822e-06
3 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 22 315 1.235e-07 3.824e-05
4 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 22 328 2.487e-07 5.775e-05
5 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 17 226 1.232e-06 0.0002289
6 REGULATORY REGION NUCLEIC ACID BINDING 36 818 1.678e-06 0.0002598
7 SEQUENCE SPECIFIC DNA BINDING 40 1037 1.071e-05 0.001422
8 SEMAPHORIN RECEPTOR ACTIVITY 4 11 3.505e-05 0.00407
9 DOUBLE STRANDED DNA BINDING 31 764 4.341e-05 0.004481
10 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 12 168 7.527e-05 0.006992
NumGOOverlapSizeP ValueAdj. P Value
1 CELL JUNCTION 48 1151 1.362e-07 7.952e-05
2 CYTOPLASMIC SIDE OF MEMBRANE 13 170 1.855e-05 0.005416
3 SEMAPHORIN RECEPTOR COMPLEX 4 11 3.505e-05 0.00571
4 CELL PROJECTION 57 1786 3.911e-05 0.00571
5 SITE OF POLARIZED GROWTH 11 149 0.0001112 0.009278
6 EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE 9 98 8.87e-05 0.009278
7 CELL LEADING EDGE 18 350 0.0001074 0.009278

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04514_Cell_adhesion_molecules_.CAMs. 10 136 0.0002342 0.04215
2 hsa04390_Hippo_signaling_pathway 10 154 0.0006299 0.05669
3 hsa04014_Ras_signaling_pathway 12 236 0.001628 0.09765
4 hsa04010_MAPK_signaling_pathway 12 268 0.004583 0.2062
5 hsa04962_Vasopressin.regulated_water_reabsorption 4 44 0.008898 0.3203
6 hsa04310_Wnt_signaling_pathway 7 151 0.02306 0.4816
7 hsa04012_ErbB_signaling_pathway 5 87 0.02316 0.4816
8 hsa04630_Jak.STAT_signaling_pathway 7 155 0.02613 0.4816
9 hsa04130_SNARE_interactions_in_vesicular_transport 3 36 0.02898 0.4816
10 hsa00604_Glycosphingolipid_biosynthesis_._ganglio_series 2 15 0.03088 0.4816
11 hsa04722_Neurotrophin_signaling_pathway 6 127 0.03155 0.4816
12 hsa04151_PI3K_AKT_signaling_pathway 12 351 0.03214 0.4816
13 hsa04360_Axon_guidance 6 130 0.03478 0.4816
14 hsa04916_Melanogenesis 5 101 0.04037 0.519
15 hsa04810_Regulation_of_actin_cytoskeleton 8 214 0.04738 0.54
16 hsa04020_Calcium_signaling_pathway 7 177 0.048 0.54
17 hsa04340_Hedgehog_signaling_pathway 3 56 0.08611 0.8615
18 hsa04540_Gap_junction 4 90 0.08706 0.8615
19 hsa04380_Osteoclast_differentiation 5 128 0.09094 0.8615
20 hsa04530_Tight_junction 5 133 0.1028 0.925
21 hsa04062_Chemokine_signaling_pathway 6 189 0.1416 1
22 hsa04660_T_cell_receptor_signaling_pathway 4 108 0.1423 1
23 hsa04520_Adherens_junction 3 73 0.1547 1
24 hsa04145_Phagosome 5 156 0.1661 1
25 hsa04512_ECM.receptor_interaction 3 85 0.2105 1
26 hsa04110_Cell_cycle 4 128 0.2156 1
27 hsa04672_Intestinal_immune_network_for_IgA_production 2 49 0.2313 1
28 hsa04912_GnRH_signaling_pathway 3 101 0.2901 1
29 hsa04621_NOD.like_receptor_signaling_pathway 2 59 0.3004 1
30 hsa04510_Focal_adhesion 5 200 0.3158 1
31 hsa04144_Endocytosis 5 203 0.3268 1
32 hsa04270_Vascular_smooth_muscle_contraction 3 116 0.3664 1
33 hsa04720_Long.term_potentiation 2 70 0.3751 1
34 hsa04730_Long.term_depression 2 70 0.3751 1
35 hsa04622_RIG.I.like_receptor_signaling_pathway 2 71 0.3817 1
36 hsa04612_Antigen_processing_and_presentation 2 78 0.4273 1
37 hsa04664_Fc_epsilon_RI_signaling_pathway 2 79 0.4337 1
38 hsa04974_Protein_digestion_and_absorption 2 81 0.4463 1
39 hsa04350_TGF.beta_signaling_pathway 2 85 0.4711 1
40 hsa04910_Insulin_signaling_pathway 3 138 0.475 1
41 hsa04640_Hematopoietic_cell_lineage 2 88 0.4892 1
42 hsa04210_Apoptosis 2 89 0.4952 1
43 hsa04666_Fc_gamma_R.mediated_phagocytosis 2 95 0.53 1
44 hsa04114_Oocyte_meiosis 2 114 0.6291 1
45 hsa04120_Ubiquitin_mediated_proteolysis 2 139 0.7337 1
46 hsa04740_Olfactory_transduction 2 388 0.9946 1

Quest ID: c13f304fe57a96a4f3d6abbc2dd3f156